{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:49:14Z","timestamp":1790880554260,"version":"4.1.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1097\/mph.0b013e318290c3d6","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T13:40:24Z","timestamp":1367674824000},"page":"e200-e204","source":"Crossref","is-referenced-by-count":41,"title":["Outcome of Children and Adolescents With a Second or Third Relapse of Acute Lymphoblastic Leukemia (ALL)"],"prefix":"10.1097","volume":"35","author":[{"given":"Bettina","family":"Reism\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N.","family":"Dworzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"P\u00f6tschger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Meister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Dieckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Gadner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andishe","family":"Attarbaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-22-20210227","first-page":"1165","article-title":"Evans WE, et al..","volume":"120","author":"Pui","year":"2012","journal-title":"Pediatric acute lymphoblastic leukemia: where are we going and how do we get there Blood"},{"key":"R2-22-20210227","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1470-2045(08)70229-8","article-title":".Bone-marrow relapse in paediatric acute lymphoblastic leukaemia.","volume":"9","author":"Bailey","year":"2008","journal-title":"Lancet Oncol"},{"key":"R3-22-20210227","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04584.x","article-title":".Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia.","volume":"123","author":"Chessells","year":"2003","journal-title":"Br J Haematol"},{"key":"R4-22-20210227","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood-2012-02-265884","article-title":".How I treat relapsed childhood acute lymphoblastic leukemia.","volume":"120","author":"Locatelli","year":"2012","journal-title":"Blood"},{"key":"R5-22-20210227","first-page":"1","article-title":".Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies.","volume":"86","author":"Uderzo","year":"2001","journal-title":"Haematologica"},{"key":"R6-22-20210227","first-page":"ELT19","article-title":"Germano G, del Giudice L, et al..","volume":"87","author":"Arico","year":"2002","journal-title":"Late relapse of childhood acute lymphoblastic leukemia and pcr-monitoring of minimal residual disease: how much time can elapse between molecular and clinical relapse Haematologica"},{"key":"R7-22-20210227","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/mpo.2950210703","article-title":".Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia.","volume":"21","author":"Buhrer","year":"1993","journal-title":"Med Pediatr Oncol"},{"key":"R8-22-20210227","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1200\/JCO.1996.14.10.2812","article-title":".Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome.","volume":"14","author":"Buhrer","year":"1996","journal-title":"J Clin Oncol"},{"key":"R9-22-20210227","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(01)06355-3","article-title":".Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia.","volume":"358","author":"Eckert","year":"2001","journal-title":"Lancet"},{"key":"R10-22-20210227","doi-asserted-by":"crossref","first-page":"7942","DOI":"10.1200\/JCO.2005.01.1031","article-title":".Long-term outcome in children with relapsed ALL by risk-stratified salvage therapy: results of trial acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group 87.","volume":"23","author":"Einsiedel","year":"2005","journal-title":"J Clin Oncol"},{"key":"R11-22-20210227","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2141.2008.07499.x","article-title":".Long-term outcome of initially homogenously treated and relapsed childhood acute lymphoblastic leukaemia in Austriaa population-based report of the Austrian Berlin-Frankfurt-Munster (BFM) Study Group.","volume":"144","author":"Reismuller","year":"2009","journal-title":"Br J Haematol"},{"key":"R12-22-20210227","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1200\/JCO.2009.25.1983","article-title":".Long-term outcome in children with relapsed acute lymphoblastic leukemia after time-point and site-of-relapse stratification and intensified short-course multidrug chemotherapy: results of trial ALL-REZ BFM 90.","volume":"28","author":"Tallen","year":"2010","journal-title":"J Clin Oncol"},{"key":"R14-22-20210227","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1038\/leu.2008.251","article-title":".Factors influencing survival after relapse from acute lymphoblastic leukemia: a Childrens Oncology Group study.","volume":"22","author":"Nguyen","year":"2008","journal-title":"Leukemia"},{"key":"R15-22-20210227","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V78.5.1166.1166","article-title":".Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85). A relapse study of the BFM group.","volume":"78","author":"Henze","year":"1991","journal-title":"Blood"},{"key":"R16-22-20210227","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/leu.2009.257","article-title":".Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000.","volume":"24","author":"Moricke","year":"2010","journal-title":"Leukemia"},{"key":"R17-22-20210227","first-page":"148","article-title":".Treatment results of childhood acute lymphoblastic leukemia in Austria--a report of 20 years experience.","volume":"114","author":"Attarbaschi","year":"2002","journal-title":"Wien Klin Wochenschr"},{"key":"R18-22-20210227","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejca.2010.09.020","article-title":".Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: a retrospective analysis of the ALL-REZ BFM Study Group.","volume":"47","author":"von Stackelberg","year":"2011","journal-title":"Eur J Cancer"},{"key":"R19-22-20210227","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1200\/JCO.2009.22.2950","article-title":".Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium study.","volume":"28","author":"Ko","year":"2010","journal-title":"J Clin Oncol"},{"key":"R20-22-20210227","doi-asserted-by":"crossref","first-page":"5750","DOI":"10.1200\/JCO.2006.07.1225","article-title":".Pathways through relapses and deaths of children with acute lymphoblastic leukemia: role of allogeneic stem-cell transplantation in Nordic data.","volume":"24","author":"Saarinen-Pihkala","year":"2006","journal-title":"J Clin Oncol"},{"key":"R21-22-20210227","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.1200\/JCO.2005.03.426","article-title":".Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Childrens Oncology Group.","volume":"23","author":"Berg","year":"2005","journal-title":"J Clin Oncol"},{"key":"R22-22-20210227","doi-asserted-by":"crossref","first-page":"6043","DOI":"10.1182\/blood-2011-08-374710","article-title":".Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.","volume":"118","author":"Hijiya","year":"2011","journal-title":"Blood"},{"key":"R23-22-20210227","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1182\/blood-2012-04-418640","article-title":".Bortezomib with chemotherapy is highly active in advanced B-precursor acute lymphoblastic leukemia: Therapeutic Advances in Childhood Leukemia Lymphoma (TACL) Study.","volume":"120","author":"Messinger","year":"2012","journal-title":"Blood"},{"key":"R24-22-20210227","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1200\/JCO.2007.15.3528","article-title":".Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Childrens Oncology Group Pilot Study.","volume":"26","author":"Raetz","year":"2008","journal-title":"J Clin Oncol"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e318290c3d6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:15:31Z","timestamp":1620965731000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-201307000-00022"}},"subtitle":["A Population-based Analysis of the Austrian ALL-BFM (Berlin-Frankfurt-M\u00fcnster) Study Group"],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318290c3d6","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}